Logo image of COO

COOPER COS INC/THE (COO) Stock Fundamental Analysis

USA - NASDAQ:COO - US2166485019 - Common Stock

68.56 USD
+0.89 (+1.32%)
Last: 9/30/2025, 8:00:01 PM
68.61 USD
+0.05 (+0.07%)
After Hours: 9/30/2025, 8:00:01 PM
Fundamental Rating

5

Overall COO gets a fundamental rating of 5 out of 10. We evaluated COO against 191 industry peers in the Health Care Equipment & Supplies industry. COO scores excellent on profitability, but there are some minor concerns on its financial health. COO is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year COO was profitable.
In the past year COO had a positive cash flow from operations.
Each year in the past 5 years COO has been profitable.
COO had a positive operating cash flow in each of the past 5 years.
COO Yearly Net Income VS EBIT VS OCF VS FCFCOO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

COO has a better Return On Assets (3.29%) than 78.01% of its industry peers.
COO's Return On Equity of 4.88% is fine compared to the rest of the industry. COO outperforms 78.01% of its industry peers.
With a decent Return On Invested Capital value of 4.50%, COO is doing good in the industry, outperforming 74.35% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for COO is significantly below the industry average of 8.97%.
The 3 year average ROIC (3.86%) for COO is below the current ROIC(4.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.29%
ROE 4.88%
ROIC 4.5%
ROA(3y)3.02%
ROA(5y)8.65%
ROE(3y)4.71%
ROE(5y)12.56%
ROIC(3y)3.86%
ROIC(5y)3.93%
COO Yearly ROA, ROE, ROICCOO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

Looking at the Profit Margin, with a value of 10.08%, COO belongs to the top of the industry, outperforming 82.72% of the companies in the same industry.
In the last couple of years the Profit Margin of COO has declined.
COO's Operating Margin of 18.31% is amongst the best of the industry. COO outperforms 89.53% of its industry peers.
COO's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 66.96%, COO is doing good in the industry, outperforming 72.25% of the companies in the same industry.
In the last couple of years the Gross Margin of COO has remained more or less at the same level.
Industry RankSector Rank
OM 18.31%
PM (TTM) 10.08%
GM 66.96%
OM growth 3Y0.82%
OM growth 5Y-2.83%
PM growth 3Y-53.59%
PM growth 5Y-10.55%
GM growth 3Y-0.14%
GM growth 5Y0.13%
COO Yearly Profit, Operating, Gross MarginsCOO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COO is destroying value.
COO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, COO has less shares outstanding
The debt/assets ratio for COO has been reduced compared to a year ago.
COO Yearly Shares OutstandingCOO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
COO Yearly Total Debt VS Total AssetsCOO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

COO has an Altman-Z score of 3.49. This indicates that COO is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.49, COO is in the better half of the industry, outperforming 70.68% of the companies in the same industry.
COO has a debt to FCF ratio of 6.02. This is a slightly negative value and a sign of low solvency as COO would need 6.02 years to pay back of all of its debts.
COO has a Debt to FCF ratio of 6.02. This is in the better half of the industry: COO outperforms 78.53% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that COO is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.30, COO is in line with its industry, outperforming 49.74% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 6.02
Altman-Z 3.49
ROIC/WACC0.56
WACC7.97%
COO Yearly LT Debt VS Equity VS FCFCOO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 2.12 indicates that COO has no problem at all paying its short term obligations.
The Current ratio of COO (2.12) is worse than 60.73% of its industry peers.
COO has a Quick Ratio of 1.24. This is a normal value and indicates that COO is financially healthy and should not expect problems in meeting its short term obligations.
COO's Quick ratio of 1.24 is on the low side compared to the rest of the industry. COO is outperformed by 67.54% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.24
COO Yearly Current Assets VS Current LiabilitesCOO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.96% over the past year.
The Earnings Per Share has been growing slightly by 3.69% on average over the past years.
The Revenue has been growing slightly by 6.35% in the past year.
Measured over the past years, COO shows a small growth in Revenue. The Revenue has been growing by 7.98% on average per year.
EPS 1Y (TTM)13.96%
EPS 3Y3.78%
EPS 5Y3.69%
EPS Q2Q%14.58%
Revenue 1Y (TTM)6.35%
Revenue growth 3Y10.05%
Revenue growth 5Y7.98%
Sales Q2Q%5.73%

3.2 Future

Based on estimates for the next years, COO will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.81% on average per year.
COO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.67% yearly.
EPS Next Y11.76%
EPS Next 2Y9.69%
EPS Next 3Y9.66%
EPS Next 5Y9.81%
Revenue Next Year4.74%
Revenue Next 2Y5.23%
Revenue Next 3Y5.43%
Revenue Next 5Y5.67%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COO Yearly Revenue VS EstimatesCOO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B 5B
COO Yearly EPS VS EstimatesCOO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.05, COO is valued on the expensive side.
COO's Price/Earnings ratio is rather cheap when compared to the industry. COO is cheaper than 82.20% of the companies in the same industry.
When comparing the Price/Earnings ratio of COO to the average of the S&P500 Index (27.76), we can say COO is valued slightly cheaper.
The Price/Forward Earnings ratio is 15.40, which indicates a correct valuation of COO.
Based on the Price/Forward Earnings ratio, COO is valued cheaper than 83.25% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.18. COO is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.05
Fwd PE 15.4
COO Price Earnings VS Forward Price EarningsCOO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

COO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. COO is cheaper than 80.10% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, COO is valued cheaper than 80.63% of the companies in the same industry.
Industry RankSector Rank
P/FCF 33.09
EV/EBITDA 14.19
COO Per share dataCOO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
COO has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.45
PEG (5Y)4.63
EPS Next 2Y9.69%
EPS Next 3Y9.66%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.02%, COO is not a good candidate for dividend investing.
COO's Dividend Yield is rather good when compared to the industry average which is at 1.79. COO pays more dividend than 90.05% of the companies in the same industry.
With a Dividend Yield of 0.02, COO pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 0.02%

5.2 History

COO has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
COO Yearly Dividends per shareCOO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.01 0.01 0.02

5.3 Sustainability

DP0%
EPS Next 2Y9.69%
EPS Next 3Y9.66%
COO Yearly Income VS Free CF VS DividendCOO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

COOPER COS INC/THE

NASDAQ:COO (9/30/2025, 8:00:01 PM)

After market: 68.61 +0.05 (+0.07%)

68.56

+0.89 (+1.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-27 2025-08-27/amc
Earnings (Next)12-03 2025-12-03/amc
Inst Owners103.27%
Inst Owner Change-1.33%
Ins Owners0.6%
Ins Owner Change3.51%
Market Cap13.63B
Analysts76.52
Price Target87.41 (27.49%)
Short Float %3.16%
Short Ratio2.37
Dividend
Industry RankSector Rank
Dividend Yield 0.02%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.17%
Min EPS beat(2)1.88%
Max EPS beat(2)2.46%
EPS beat(4)3
Avg EPS beat(4)1.81%
Min EPS beat(4)-0.21%
Max EPS beat(4)3.11%
EPS beat(8)6
Avg EPS beat(8)2.46%
EPS beat(12)8
Avg EPS beat(12)1.13%
EPS beat(16)9
Avg EPS beat(16)0.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.82%
Min Revenue beat(2)-1.37%
Max Revenue beat(2)-0.27%
Revenue beat(4)0
Avg Revenue beat(4)-1.44%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)-0.27%
Revenue beat(8)1
Avg Revenue beat(8)-0.97%
Revenue beat(12)5
Avg Revenue beat(12)-0.26%
Revenue beat(16)9
Avg Revenue beat(16)0.17%
PT rev (1m)-8.73%
PT rev (3m)-10.26%
EPS NQ rev (1m)-0.86%
EPS NQ rev (3m)-0.56%
EPS NY rev (1m)0.49%
EPS NY rev (3m)0.6%
Revenue NQ rev (1m)-2.63%
Revenue NQ rev (3m)-2.46%
Revenue NY rev (1m)-0.77%
Revenue NY rev (3m)-0.72%
Valuation
Industry RankSector Rank
PE 17.05
Fwd PE 15.4
P/S 3.37
P/FCF 33.09
P/OCF 16.7
P/B 1.63
P/tB 4.77
EV/EBITDA 14.19
EPS(TTM)4.02
EY5.86%
EPS(NY)4.45
Fwd EY6.49%
FCF(TTM)2.07
FCFY3.02%
OCF(TTM)4.11
OCFY5.99%
SpS20.35
BVpS42.01
TBVpS14.36
PEG (NY)1.45
PEG (5Y)4.63
Profitability
Industry RankSector Rank
ROA 3.29%
ROE 4.88%
ROCE 6.52%
ROIC 4.5%
ROICexc 4.55%
ROICexgc 8.87%
OM 18.31%
PM (TTM) 10.08%
GM 66.96%
FCFM 10.18%
ROA(3y)3.02%
ROA(5y)8.65%
ROE(3y)4.71%
ROE(5y)12.56%
ROIC(3y)3.86%
ROIC(5y)3.93%
ROICexc(3y)3.91%
ROICexc(5y)3.98%
ROICexgc(3y)7.96%
ROICexgc(5y)8.62%
ROCE(3y)5.65%
ROCE(5y)5.73%
ROICexcg growth 3Y7.03%
ROICexcg growth 5Y-21.56%
ROICexc growth 3Y2.56%
ROICexc growth 5Y-10.24%
OM growth 3Y0.82%
OM growth 5Y-2.83%
PM growth 3Y-53.59%
PM growth 5Y-10.55%
GM growth 3Y-0.14%
GM growth 5Y0.13%
F-Score9
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 6.02
Debt/EBITDA 2.23
Cap/Depr 109.3%
Cap/Sales 10%
Interest Coverage 250
Cash Conversion 73.48%
Profit Quality 101.01%
Current Ratio 2.12
Quick Ratio 1.24
Altman-Z 3.49
F-Score9
WACC7.97%
ROIC/WACC0.56
Cap/Depr(3y)96.32%
Cap/Depr(5y)93.28%
Cap/Sales(3y)9.68%
Cap/Sales(5y)9.83%
Profit Quality(3y)87.75%
Profit Quality(5y)70.99%
High Growth Momentum
Growth
EPS 1Y (TTM)13.96%
EPS 3Y3.78%
EPS 5Y3.69%
EPS Q2Q%14.58%
EPS Next Y11.76%
EPS Next 2Y9.69%
EPS Next 3Y9.66%
EPS Next 5Y9.81%
Revenue 1Y (TTM)6.35%
Revenue growth 3Y10.05%
Revenue growth 5Y7.98%
Sales Q2Q%5.73%
Revenue Next Year4.74%
Revenue Next 2Y5.23%
Revenue Next 3Y5.43%
Revenue Next 5Y5.67%
EBIT growth 1Y15.23%
EBIT growth 3Y10.95%
EBIT growth 5Y4.93%
EBIT Next Year27.03%
EBIT Next 3Y14.43%
EBIT Next 5Y9.53%
FCF growth 1Y85.88%
FCF growth 3Y-18.09%
FCF growth 5Y-7.31%
OCF growth 1Y44.73%
OCF growth 3Y-1.34%
OCF growth 5Y-0.11%